Methicillin-resistant Staphylococcus Aureus (MRSA) Infection

Also known as: MRSA - Methicillin Resistant Staphylococcus Aureus Infection / Methicillin-Resistant Staphylococcus Aureus Infection / Methicillin Resistant Staphylococcus Aureus Infection (MRSA) / Methicillin resistant Staphylococcus aureus infection, unspecified site / Methicillin-resistant staphylococcus aureus infection (disorder) / Oxacillin-resistant Staphylococcus aureus infection / Infection MRSA / Staphylococcal infection, unspecified site / Bacterial infection due to unspecified staphylococcus / Infection staphylococcal / Staphylococcal infection NOS / Staphylococcal infectious disease (disorder) / Staphylococcal infection / Staphylococcal Infections

DrugDrug NameDrug Description
DB01764DalfopristinAn antibiotic used with quinupristin to treat severe or life-threatening infections of vancomycin-resistant Enterococcus faecium (VREF), and skin infections caused by methicillin susceptible staphylococcus aureus or streptococcus pyogenes.
DB12455OmadacyclineA tetracycline antibiotic used to treat community acquired bacterial pneumonia.
DB01369QuinupristinAn antibiotic agent used in the treatment of serious vancomycin-resistant Enterococcus faecium bacteremia as well as complicated skin and skin structure infections.
DrugDrug NamePhaseStatusCount
DB00435Nitric Oxide2Terminated1
DB00878Chlorhexidine4Active Not Recruiting1
DB00878Chlorhexidine4Terminated1
DB00410Mupirocin4Active Not Recruiting1
DB00410Mupirocin4Terminated1
DB00512Vancomycin4Terminated1
DB01190ClindamycinNot AvailableTerminated1
DB01015SulfamethoxazoleNot AvailableCompleted1
DB00440TrimethoprimNot AvailableCompleted1